Serum Free Light Chain Assay as a Prognostic Marker in Patients with Aggressive B-Cell Non-Hodgkin's Lymphoma: Impact on Survival Outcome

Abstract T.M. Anoop Background The role of serum free light chain (FLC) as a prognostic biomarker in lymphoproliferative diseases is being increasingly studied. In this study we present the 5-year sur...

Full description

Bibliographic Details
Main Authors: T.M. Anoop, Geetha Narayanan, Steffi Chacko, K.M. Jagathnath Krishna, Sreejith G. Nair
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022-07-01
Series:South Asian Journal of Cancer
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1743426